MET‑RON dual inhibitor, BMS‑777607, suppresses cholangiocarcinoma cell growth, and MET‑RON upregulation indicates worse prognosis for intra‑hepatic cholangiocarcinoma patientsChi‐Tung Cheng, Chun‐Nan Yeh|Oncology Reports|2018Cited by 7
Abstract 1309: Identification of aurora kinase a as an unfavorable prognostic factor and potential treatment target for metastatic gastrointestinal stromal tumorsChun‐Nan Yeh, Jonathan A. Fletcher, Yeng-Yang Chen et al.|Cancer Research|2014Cited by 0